“MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate As Therapeutic Adjuvants”. Integrated Health Research Journal, vol. 3, no. (1-Supp), June 2026, pp. 05-16, https://doi.org/10.47963/ihrj.v3i(1-Supp).2075.